The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 5, 1997, Pages 1699-1704

  Aris, Robert M ^a   Gilligan, Peter H ^a   Neuringer, Isabel P ^a   Gott, Kristi K ^a   Rea, Jean ^a   Yankaskas, James R ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; AZATHIOPRINE; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN A; CYTOMEGALOVIRUS ANTIBODY; IMIPENEM; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; OKT 3; PIPERACILLIN; PREDNISONE; THYMOCYTE ANTIBODY; TIMENTIN; TOBRAMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BRONCHIOLITIS; BRONCHITIS; BURKHOLDERIA CEPACIA; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG LAVAGE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PNEUMONIA; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; TREATMENT OUTCOME; VENTILATOR;

EID: 0030976883     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.5.9154879     Document Type: Article

References (28)

1. FitzSimmons, S. C. 1993. The changing epidemiology of cystic fibrosis. J. Pediatr. 122:1-9.
2. Egan, T. M., F. C. Detterbeck, M. R. Mill, L. J. Paradowski, R. P. Lackner, W. D. Ogden, J. R. Yankaskas, J. H. Westerman, J. T. Thompson, M. A. Weiner, E. L. Cairns, and B. R. Wilcox. 1995. Improved results of lung transplantation for patients with cystic fibrosis. J. Thorac. Cardiovasc. Surg. 109:224-235.
3. Ramirez, J. C., G. A. Patterson, T. L. Winton, A. L. de Hoyos, J. D. Miller, J. R. Maurer, and The Toronto Lung Transplant Group. 1992. Bilateral lung transplantation for cystic fibrosis. J. Thorac. Cardiovasc. Surg. 103: 287-294.
4. Starnes, V. A., N. Lewiston, J. Theodore, C. Stoehr, E. Stinson, N. E. Shumway, and P. E. Oyer. 1992. Cystic fibrosis: target population for lung transplantation in North America in the 1990s. J. Thorac. Cardiovasc. Surg. 103:1008-1014.
5. Cooper, J. D., and M. S. Pohl. 1996. The St. Louis International Lung Transplant Registry, April semi-annual report.
6. Kotloff, R. M, and J. B. Zuckerman. 1996. Lung transplantation for cystic fibrosis: special considerations. Chest 109:787-798.
7. Bosso, J. A., J. E. Allen, and J. M. Matsen. 1989. Changing susceptibility of Pseudomonos aeruginosa isolates from cystic fibrosis patients with the clinical use of newer antibiotics. Antimicrob. Agents Chemother. 33:526-528.
8. Yankaskas, J. R., and G. Mallory, chairmen. Lung Transplantation and Cystic Fibrosis Consensus Conference. Washington, DC., May 22-23, 1996.
9. Hasan, A., P. A. Corris, N. Wrightson, A. D. Gascoigne, D. A. Waller, I. Wilson, C. J. Hilton, F. K. Gould, J. Forty, and J. H. Dark. 1995. Bilateral sequential lung transplantation for end stage septic lung disease. Thorax 50:565-566.
10. Snell, G. I., A. de Hoyos, M. Krajden, T. Winton, and J. R. Maurer. 1993. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest 103:466-471.
11. Dennis, C., N. Caine, L. Sharples, R. Smyth, T. Higenbottam, S. Stewart, T. Wreghitt, S. Large, F. C. Wells, and J. Wallwork. 1993. Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth hospital. J. Heart Lung Transplant. 12:893-902.
12. Madden, B. P., M. E. Hodson, V. Tsang, R. Radley-Smith, A. Khaghani, and M. Y. Yacoub. 1992. Intermediate-term results of heart-lung transplantation for cystic fibrosis. Lancet 1:1583-1587.
13. Shennib, H., M. Noirclerc, P. Ernst, D. Metras, D. S. Mulder, R. Giudicelli, F. Lebel, J.-F. Dumon, and the Cystic Fibrosis Transplant Study Group. 1992. Double-lung transplantation for cystic fibrosis. Ann. Thorac. Surg. 54:27-32.
14. Tamm, M., and T. Higenbottam. 1994. Heart-lung and lung transplantation for cystic fibrosis: world experience. Semin. Respir. Crit. Care Med. 15:414-425.
15. Griffith, B. P., R. L. Hardesty, J. M. Armitage, B. G. Hattler, R. J. Keenan, and I. Paradis. 1993. A decade of lung transplantation. Ann. Surg. 218:310-320.
16. Flume, P. A., T. M. Egan, L. J. Paradowski, F. C. Detterbeck, J. T. Thompson, and J. R. Yankaskas. 1994. Infectious complications of lung transplantation: a comparison of patients with cystic fibrosis and other indications. Am. Rev. Respir. Dis. 149:1601-1617.
17. Pasque, M. K., J. D. Cooper, L. R. Kaiser, D. A. Haydock, A. Triantafillou, and B. Trulock. 1990. Improved technique for bilateral lung transplantation: rationale and initial clinical experience. Ann. Thorac. Surg. 49:785-791.
18. Gilligan, P. H. 1991. Microbiology of airway disease in patients with cyslic fibrosis. Rev. Clin. Microbiol. 4:35-51.
19. Murray, P. R., E. J. Baron, M. A. Pfallen, F. C. Tenover, and R. H. Yolken. 1995. Manual of Clinical Microbiology, 6th ed. AMS Press, Washington, DC.
20. National Committee on Clinical Laboratory Standards. 1995. Performance Standards for Antimicrobial Susceptibility Testing. Document M100-56, Vol. 15, No. 14.
21. Aris, R. M., I. P. Neuringer, M. A. Weiner, T. M. Egan, and D. Ontjes. 1996. Severe osteoporosis before and after lung transplantation. Chest 109:1176-1183.
22. Yousem, S. A., G. J. Berry, E. M. Brunt, D. Chamberlain, R. H. Hriban, R. K. Sibley, S. Stewart, and H. D. Tazellar. 1990. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: lung rejection study group. J. Heart Transplant. 9: 593-601.
23. Colton, T. 1974. Statistics in Medicine. 1st ed. Little, Brown Co., Boston. 174-183.
24. Tsang, V., T. L. Pitt, M. E. Kaufmann, H. Gaya, M. E. Hodson, and M. Yacoub. 1994. Colonization of lung allografts with Pseudomonas aeruginosa in heart-lung transplant recipients with cystic fibrosis. Thorax 49:721-722.
25. Saiman, L. New management approaches to Pseudomonas aeruginosa infections in cystic fibrosis. 1994. New Insights into Cystic Fiborsis 2:6-9.
26. Morris, G., and M. R. W. Brown. 1988. Novel modes of action of aminoglycoside antibiotics against Pseudomonas aeruginosa. Lancet 1:1359-1360.
27. Sun, L., R. Z. Jiang, S. Steinbeck, A. Holmes, C. Campanelli, J. Forstner, V. Sajjen, Y. Tan, and R. Goldstein. 1995. The emergence of a highly transmissible strain of cbl+ Pseudomonas (Burkholderia) cepacia causing CF center epidemics in North America and Britain. Nat. Med. 7:661-666.
28. Gilligan, P. H. 1996. Report on the consensus document for microbiology and infectious diseases in cystic fibrosis. Clin. Microbiol. News 18:83-87.